博九娱乐网

Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in their core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Their technologies enable them to find innovative solutions for affordable…More biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.